The biological role of the released caspase-4 from unstable COPD-derived PBMCs is still under-investigated, and it still remains to investigate how caspase-4 is involved in IL-18 and IL-33 levels from PBMCs of unstable COPD patients. This evidence concerns the gene IL33 and chronic obstructive pulmonary disease.